-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, JgPTZKhAEc1Jw12gHX5xKdau19z3JhAGRSKMawqzhkfqSLxPF5DkCQO/9Vu1ROjA 8SipxvoxwPB7mI+1fi3hvA== /in/edgar/work/20000728/0000950135-00-003673/0000950135-00-003673.txt : 20000921 0000950135-00-003673.hdr.sgml : 20000921 ACCESSION NUMBER: 0000950135-00-003673 CONFORMED SUBMISSION TYPE: 8-A12G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20000728 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MEDICINES CO/ MA CENTRAL INDEX KEY: 0001113481 STANDARD INDUSTRIAL CLASSIFICATION: [2834 ] IRS NUMBER: 043324394 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-A12G SEC ACT: SEC FILE NUMBER: 000-31191 FILM NUMBER: 681133 BUSINESS ADDRESS: STREET 1: ONE CAMBRIDGE CTR CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 6172259099 8-A12G 1 e8-a12g.txt FORM 8-A 1 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-A For Registration of Certain Classes of Securities Pursuant to Section 12(b) or (g) of the Securities Exchange Act of 1934 The Medicines Company ----------------------------------------------------- (Exact name of registrant as specified in its charter) DELAWARE 04-3324394 -------- ---------- (State of incorporation (IRS Employer or organization) Identification No.) One Cambridge Center, Cambridge, Massachusetts 02142 ---------------------------------------------------- (Address of principal executive offices) (Zip Code)
If this form relates to the registration of a class of If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act securities pursuant to Section 12(g) of the Exchange and is effective pursuant to General Instruction A.(c), Act and is effective pursuant to General please check the following box. [ ] Instruction A.(d), please check the following box. [x] Securities Act registration statement file number to which this form relates: 333-37404 --------- (If applicable) Securities to be registered pursuant to Section 12(b) of the Act: None
Title of Each Class Name of Each Exchange on Which to be so Registered Each Class is to be Registered ------------------- ------------------------------ Securities to be registered pursuant to Section 12(g) of the Act: Common Stock, $0.001 par value per share ---------------------------------------- Title of Class) 2 Item 1: Description of Registrant's Securities to be Registered. -------------------------------------------------------- The description under the heading "Description of Capital Stock" relating to the Registrant's Common Stock, $.001 par value per share, in the Prospectus included in the Registrant's Registration Statement on Form S-1 filed with the Securities and Exchange Commission (the "Registration Statement on Form S-1") (File No. 333-37404) is incorporated herein by reference. Item 2: Exhibits. --------- The following exhibits are filed herewith (or incorporated by reference as indicated below): 1. Second Amended and Restated Certificate of Incorporation of the Registrant, incorporated by reference to Exhibit 3.1 to the Company's Registration Statement on Form S-1. 2. Form of Certificate of Amendment to Second Amended and Restated Certificate of Incorporation of the Registrant, incorporated by reference to Exhibit 3.2 to the Company's Registration Statement on Form S-1. 3. Form of the Third Amended and Restated Certificate of Incorporation of the Registrant, incorporated by reference to Exhibit 3.3 to the Company's Registration Statement on Form S-1. 4. By-laws of the Registrant, incorporated by reference to Exhibit 3.4 to the Company's Registration Statement on Form S-1. 5. Amended and Restated Bylaws of the Registrant, incorporated by reference to Exhibit 3.5 to the Company's Registration Statement on Form S-1. SIGNATURE Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the Registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereto duly authorized. The Medicines Company By: /s/ Peyton Marshall ---------------------------------------- Peyton Marshall Chief Financial Officer and Vice President July 28, 2000
-----END PRIVACY-ENHANCED MESSAGE-----